Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.
about
Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical modelRecombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study.Advances in interleukin 2 receptor targeted treatmentElevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytesDystrophia myotonia: why focus on foci?FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapiesMolecular and cellular mechanisms of ectodomain sheddingNeonatal Immune Tolerance Induction to Allow Long-Term Studies With an Immunogenic Therapeutic Monoclonal Antibody in MiceSerum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptorTumor markers in hairy cell leukemia.The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease.Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.Total lesion glycolysis as an IgG4-related disease activity marker.Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning.
P2860
Q28544295-12CA7EA6-661D-40B2-8665-9EFB90D3F49EQ33606102-0D21622F-12B3-4CA3-AB61-CE494EA80931Q34071328-EE7DB2AC-3056-4879-AAF5-1AE998FE3188Q34244205-C196741A-5455-4176-A8E0-A47305B6A959Q34326165-42B588CD-4250-44C9-A60A-82C12185E61CQ35670904-892506F6-4C19-4C1D-97E2-F63D35F03A2FQ35888457-41EB8534-E797-4FFE-9D28-AD5EEE9C3020Q36210626-654BB964-F5A2-4C95-AAF6-895092ACDDB8Q36653919-0EA0523D-8012-42D4-B66C-57C953D5A1A0Q36956380-48435DD6-A3E6-4B88-9751-53BA06B3A01BQ37590654-206FC638-B35E-4BCA-9006-0F6DFCF40762Q37861182-A01EA7D7-EA4D-43CC-907D-75C20D6F25AFQ39338052-244517CD-D4E2-4F71-9C9A-00259BF3B8ADQ40097601-E66A64C8-A8CC-4DD8-96F0-99F97DC4DD6AQ47282483-9E0AF389-075A-4698-B0DF-74D1F04A275BQ48003065-76588DA9-31F7-4F3B-ADD6-7D7171FCDD88Q50608230-EC0712B9-A183-4BAB-8CDF-D108B531FFE9Q53063696-9A9A801E-80DD-447E-9799-F9E6C0DA7749
P2860
Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@ast
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@en
type
label
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@ast
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@en
prefLabel
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@ast
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@en
P2860
P356
P1476
Metabolism of Tac (IL2Ralpha): ...... atabolism by antibody binding.
@en
P2093
Junghans RP
Waldmann TA
P2860
P304
P356
10.1084/JEM.183.4.1587
P407
P577
1996-04-01T00:00:00Z